Celyad Oncology SA (FRA:1C0)
0.1785
+0.0010 (0.56%)
Last updated: Dec 1, 2025, 8:35 AM CET
Celyad Oncology Market Cap
Celyad Oncology has a market cap or net worth of €8.71 million as of December 1, 2025. Its market cap has decreased by -67.67% in one year.
Market Cap
8.71M
Enterprise Value
8.75M
Revenue
186.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.18
Market Cap Chart
Since July 4, 2013, Celyad Oncology's market cap has decreased from 101.99M to 8.71M, a decrease of -91.46%. That is a compound annual growth rate of -17.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 8.71M | -70.48% |
| Dec 31, 2024 | 29.50M | 82.56% |
| Dec 29, 2023 | 16.16M | 41.33% |
| Dec 30, 2022 | 11.43M | -85.60% |
| Dec 31, 2021 | 79.42M | -13.96% |
| Dec 31, 2020 | 92.30M | -31.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.28B |
| Siemens Aktiengesellschaft | 175.16B |
| Allianz SE | 140.57B |
| Deutsche Telekom AG | 131.53B |
| Siemens Energy AG | 95.89B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.36B |
| Rheinmetall AG | 66.44B |
| Deutsche Bank Aktiengesellschaft | 58.14B |